[免疫透和临床特征分析结血相关基因在败血症]
Yan Xing1, Meng Cheng, Yueli Dong
1Department of Pediatric Intensive Care Unit, Zhengzhou University People's Hospital (Henan University Clinical Medical School, Henan Provincial People's Hospital), Zhengzhou 450003, China. Corresponding author: Xing Yan,
Zhonghua wei zhong bing ji jiu yi xue
|March 15, 2026
概括
这项研究确定CD163是败血症诱导的免疫凝血病的关键基因,将其上调与疾病严重程度和凝血病联系起来. 人类重组血栓形成素 (hrTPO) 显示出改善这些败血症相关并发症的潜力.
科学领域:
- 败血症的研究研究.
- 免疫学 免疫学 免疫学
- 凝血障碍 凝血障碍 凝血障碍
背景情况:
- 败血症涉及复杂的免疫和凝血系统失调.
- 在败血症引起的凝血病中识别关键基因对于向治疗至关重要.
研究的目的:
- 为了分析免疫透和结血相关的基因在败血症.
- 揭示与凝血相关的差异表达基因 (CRDEGs) 在败血症中的作用.
- 探索毒引起的凝血病的潜在治疗点.
主要方法:
- 对GEO数据集的生物信息分析以识别CRDEG并构建蛋白质-蛋白质相互作用网络.
- 使用算法和ROC曲线分析进行关键基因识别以获得诊断价值.
- 免疫细胞透分析和与关键基因的相关性研究.
- 使用SD大鼠进行动物模型验证,以评估关键指标和分子标记.
- 评估人类重组血栓形成素 (hrTPO) 的干预效应.
主要成果:
- 确定了59种CRDEG,其中25种表现出显著的差异性表达.
- CD163,MMP-9,CCL5,CCR5和CD8A被确定为关键基因;CD163显示出高的诊断准确性 (AUC=0.746).
- CD163与巨细胞透和败血症严重程度有很强的相关性.
- 动物模型证实,败血症-DIC加重了凝血病,由改变的CD163,ADAMTS-13,vWF,miR-150和p65水平证明.
- hrTPO干预改善了这些指标在败血症-DIC大鼠.
结论:
- CD163是一种潜在的核心基因在败血症诱导的免疫凝血病.
- CD163和NF-κB的上调,与miR-150的下调,与败血症严重程度和凝血病相关.
- hrTPO证明了对败血症诱导的凝血病的潜在治疗益处.
相关概念视频
01:09Coagulation
11.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.6K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
14.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
01:25Endocarditis II: Clinical Features of Infective Endocarditis
704
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
704